Questions About Cancer? 1-800-4-CANCER
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Popular Resources

Funding Opportunities

Funding Opportunities by Type

  • Requests for Applications

    Find current and recent NCI-supported RFAs that provide funding for various areas of cancer research.

  • Program Announcements

    Find current and recent PAs that invite requests for funding applications to support specific area of cancer research.

  • Research Project Grants

    Find current and recent NCI and Trans-NIH Research Project Grants (R01 and R21) that provide funding for specific areas of cancer research.

  • Requests for Proposals for Contracts

    Find opportunities for contract funding.

  • NCI Cleared Concepts

    Find concepts for future RFAs and PAs that provide an early alert to applicants of upcoming funding opportunities.

Training Opportunities

NCI Special Initiative

  • Provocative Questions Program

    PQ is a NCI initiative that intends to assemble a list of important questions, or problems that are paradoxes in cancer research that will stimulate research communities to use laboratory, clinical, and population sciences in new, effective, and imaginative ways.

NCI Funding Opportunities by Research Topic

  • Basic Biology

    Research projects in basic cancer biology are supported and coordinated through the Division of Cancer Biology (DCB).

  • Biorepositories and Tissue Sample Collection

    Development of biospecimen-related policies and practices affecting NCI Biorepositories is coordinated and managed through the Office of Biorepositories and Biospecimen Research (OBBR).

  • Complementary and Alternative Medicine

    Research contributing to the advancement of evidence-based complementary and alternative medicine practice is supported by the Office of Cancer Complementary and Alternative Medicine (OCCAM).

  • Epidemiology

    Research in genetic, epidemiologic, behavioral, social, and surveillance cancer research is supported by the Division of Cancer Control and Population Sciences (DCCPS).

  • Genomics – sequencing

    Research aimed at accelerating our understanding of the molecular basis of cancer through the application of genome analysis technologies and is supported by The Cancer Genome Atlas Program (TCGA).

  • HIV /AIDS and Cancer

    Research on HIV/AIDS pursued throughout the NCI, including programs in AIDS-related cancer are coordinated by the Office of HIV and AIDS Malignancy (OHAM).

  • Nanotechnology

    Research supporting the application of nanotechnology to all aspects of cancer research is supported by the NCI Alliance for Nanotechnology in Cancer program that managed by the Office of Cancer Nanotechnology Research (OCNR).

  • Physical Sciences-Oncology

    Research supporting the establishment of scientific teams and individual scientists from the fields of physics, mathematics, chemistry, and engineering to develop novel approaches for cancer research is managed by the Office of Physical Sciences-Oncology (OPSO).

  • Prevention

    Research that determines and reduces a person’s risk of developing cancer, as well as research to develop and evaluate cancer screening procedures, is supported by the Division of Cancer Prevention (DCP).

  • Proteomics

    Research supporting the development of technologies and reagents that will advance our understanding of protein biology in cancer is supported by the Office of Cancer Clinical Proteomics (OCCPR).

  • Small Business and Small Business Technology Transfer

    Opportunities to increase small business and private sector participation to develop and commercialize novel technologies to prevent, diagnose, and treat cancer are managed by the Small Business & Small Business Technology Transfer SBIR and STTR programs (SBIR/STTR).

  • Statistical Methodology

    Resources for statisticians are available from StatFund, an online resource that provides information about biostatistical funding opportunities.

  • Technology Development

    Research supporting the development of technologies in clinical, laboratory, and epidemiological research are managed by the Innovative Molecular Analysis Technologies Program (IMAT).

  • Translational Research

    Research supporting the translation of promising research areas into improved diagnostic and therapeutic interventions for cancer patients is supported by the Division of Cancer Treatment and Diagnosis (DCTD).